Abbott Laboratories

The current price of ABT is $113.38 — it has decreased by 1.85% since the previous close. Data as of Nov 5, 2026.

ABT is up 6.81% over the past week, up 13.26% over the past month and down 8.96% over the past year. The price is above its 200-day moving average of $101.54.

Analysts' average 12-month price target for ABT is $121.36, which implies 7.04% upside from the current price. Individual estimates range from $112.00 to $130.00.

Of the 28 analysts covering Abbott Laboratories, 5 rate it a strong buy, 18 rate it a buy and 5 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.

Abbott Laboratories has a market capitalization of $196.18B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Abbott Laboratories posted earnings of $1.42 per share, in line with the estimate of $1.42. Upcoming reports are listed in the earnings calendar.

Abbott Laboratories reported revenue of $13.01B in its most recent quarter, which has increased by 14.46% compared with the same quarter a year earlier. Analysts had expected $12.99B.

Yes. Abbott Laboratories pays dividends quarterly. The latest payment of $0.63 per share has a payment date of Nov 16, 2026, which corresponds to a dividend yield of 2.41%.

Companies most comparable to Abbott Laboratories include Johnson & Johnson, Thermo Fisher Scientific Inc., Danaher Corporation, Medtronic Plc and Stryker Corporation.

In the latest trading session ABT moved between $113.24 and $117.00, a range of 3.32% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Abbott Laboratories shows a buy rating today. Technical ratings are indicators, not investment advice.

Over the past 52 weeks ABT has traded between $81.97 and $132.03. The current price is 14.13% below its 52-week high.